BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7976500)

  • 1. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.
    Rixon RH; Whitfield JF; Gagnon L; Isaacs RJ; Maclean S; Chakravarthy B; Durkin JP; Neugebauer W; Ross V; Sung W
    J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH)(1-28)NH2.
    Whitfield JF; Morley P; Willick GE; Isaacs RJ; MacLean S; Ross V; Barbier JR; Divieti P; Bringhurst FR
    J Bone Miner Res; 2000 May; 15(5):964-70. PubMed ID: 10804028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats.
    Whitfield JF; Morley P; Willick G; Langille R; Ross V; MacLean S; Barbier JR
    J Bone Miner Res; 1997 Aug; 12(8):1246-52. PubMed ID: 9258755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of femoral trabecular bone growth in ovariectomized rats by human parathyroid hormone (hPTH)-(1-30)NH(2).
    Whitfield JF; Morley P; Willick GE; MacLean S; Ross V; Barbier J; Isaacs RJ
    Calcif Tissue Int; 1999 Aug; 65(2):143-7. PubMed ID: 10430648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin).
    Whitfield JF; Morley P; Willick GE; Ross V; Barbier JR; Isaacs RJ; Ohannessian-Barry L
    Calcif Tissue Int; 1996 Feb; 58(2):81-7. PubMed ID: 8998682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34.
    Whitfield JF; Isaacs RJ; Chakravarthy B; Maclean S; Morley P; Willick G; Divieti P; Bringhurst FR
    J Bone Miner Res; 2001 Mar; 16(3):441-7. PubMed ID: 11277261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
    Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
    Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
    Lane NE; Kimmel DB; Nilsson MH; Cohen FE; Newton S; Nissenson RA; Strewler GJ
    J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1-34).
    Whitfield JF; Morley P; Ross V; Isaacs RJ; Rixon RH
    Calcif Tissue Int; 1995 Mar; 56(3):227-31. PubMed ID: 7750029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
    Hock JM; Hummert JR; Boyce R; Fonseca J; Raisz LG
    J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the abilities of human parathyroid hormone (hPTH)-(1-34) and [Leu27]-cyclo(Glu22-Lys26)-hPTH-(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats.
    Whitfield JF; Morley P; Willick G; MacLean S; Ross V; Isaacs RJ; Barbier JR
    Calcif Tissue Int; 1998 Nov; 63(5):423-8. PubMed ID: 9799828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the abilities of human parathyroid hormone(1-31)NH2 and human parathyroid hormone-related protein(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats.
    Whitfield JF; Morley P; Willick GE; Ross V; Langille R; MacLean S; Barbier J; Isaacs RJ; Ohannessian-Barry L
    Calcif Tissue Int; 1997 Oct; 61(4):322-6. PubMed ID: 9312203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Takano Y; Tanizawa T; Mashiba T; Endo N; Nishida S; Takahashi HE
    J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis.
    Ibbotson KJ; Orcutt CM; D'Souza SM; Paddock CL; Arthur JA; Jankowsky ML; Boyce RW
    J Bone Miner Res; 1992 Apr; 7(4):425-32. PubMed ID: 1609630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further definition of the protein kinase C activation domain of the parathyroid hormone.
    Jouishomme H; Whitfield JF; Gagnon L; Maclean S; Isaacs R; Chakravarthy B; Durkin J; Neugebauer W; Willick G; Rixon RH
    J Bone Miner Res; 1994 Jun; 9(6):943-9. PubMed ID: 8079668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.